Dyadic Applied BioSolutions
Jupiter · Founded 1979
About Dyadic Applied BioSolutions
Dyadic Applied BioSolutions is a global biotechnology company headquartered in Jupiter, Florida with its research and development center in the Netherlands. Dyadic uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzyme industries. Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 fungus which enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes and proteins. Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes which these technologies help produce
Company Facts
- Founded: 1979
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $16.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nasdaq:DYAI
- Website: dyadic.com
- Phone: +1 561-743-8333
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/dyadic-applied-biosolutions-16065 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.